Irritable Bowel Syndrome (IBS) Therapeutics Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2025

Irritable Bowel Syndrome (IBS) Therapeutics

Irritable Bowel Syndrome (IBS) Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome (IBS) Therapeutics market based on company, product type, end user and key regions.

IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.

This report studies the global market size of Irritable Bowel Syndrome (IBS) Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome (IBS) Therapeutics in these regions.

This research report categorizes the global Irritable Bowel Syndrome (IBS) Therapeutics market by top players/brands, region, type and end user. This report also studies the global Irritable Bowel Syndrome (IBS) Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Abbott Laboratories
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Valeant Pharmaceuticals International
  • Ardelyx
  • Astellas Pharma
  • Novartis
  • GlaxoSmithKline
  • Ironwood Pharmaceuticals

Market size by Product

  • Blautix (Strain)
  • Bekinda (IBS-D)
  • SYN-010
  • Tenapanor
Report Sample includes:
– Table of Contents
– List of Tables & Figures
– Charts
– Research Methodology

Get FREE Sample of this Report at

Market size by End User

  • Hospital
  • Research

Market size by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea

The study objectives of this report are:

  • To study and analyze the global Irritable Bowel Syndrome (IBS) Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Irritable Bowel Syndrome (IBS) Therapeutics market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Irritable Bowel Syndrome (IBS) Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Irritable Bowel Syndrome (IBS) Therapeutics submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) Therapeutics are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome (IBS) Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170

Follow Us On linkedin :-


Please enter your comment!
Please enter your name here